Blockchain Registration Transaction Record

GeoVax to Showcase Advancements in Vaccines & Immunotherapies at 2025 BIO CEO & Investor Conference

GeoVax Labs, Inc. to present strategic vision and milestones at 2025 BIO CEO & Investor Conference. Company developing vaccines for infectious diseases and solid tumor cancers, including next-gen COVID-19 vaccine GEO-CM04S1. Learn more about GeoVax's innovative approach.

GeoVax to Showcase Advancements in Vaccines & Immunotherapies at 2025 BIO CEO & Investor Conference

This news matters as it highlights GeoVax's innovative approach to developing vaccines for infectious diseases and solid tumor cancers, including a next-generation COVID-19 vaccine. The presentation at the conference signifies the company's commitment to advancing immunotherapies and vaccines to address global health challenges.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x9da629593b0b62f6a13e7766e9e5ba1990ea0edf5d2b40d6240e2a9f47000e18
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintlambBsL0-4617f9312313bd54014d45c82359733c